O.A. Polyakova, L.D. Kozgunova, O.D. Ostroumova
Metabolically associated fatty liver disease: the role of ademetionine
|
№1-2 / 2023
|
E.V.Biron, M.B. of Kalinina
Drug-induced Liver Injuries In Patients With Tuberculosis And Potentials For Their Correction
|
№4 / 2013
|
I.V. Maev, MD, T.E. Polunina
Medicines And Liver
|
№2 / 2013
|
A.N. Kazyulin, L.Z. Velsher, N.N. Danilevskaya, E. A.Mayevskaya
Drug-induced Hepatotoxicity During Chemotherapy For Oncological Diseases And Potentials For Its Correction
|
№8 / 2012
|
Polunina T.E.
Strategy For Diagnosis And Treatment Of Alcoholic Liver Disease
|
№7 / 2012
|
D.T. Abdurakhmanov, S.V. Moiseyev
Drug-induced Liver Injuries
|
№17 / 2011
|
I.V. Mayev, V.V. Tsukanov, A.A. Samsonov, Yu.L. Tonkikh, A.V. Vasyutin, Yu.A. Kucheryavy
Pathogenesis And Principles Of Treatment Of Alcoholic Liver Disease
|
№11 / 2011
|
L.A. Zvenigorodskaya
Lipid-lowering Therapy In Patients With Nonalcoholic Fatty Liver Disease
|
№10 / 2011
|
Pticina S.N.
Unique Role Of Ademetionine In Cell Metabolism And Its Pharmacological Potential
|
№20 / 2010
|
A.N. Kazyulin, L.Z. Vel’cher, I.A. Koroleva
Hepatotoxicity During Anticancer Chemotherapy Of Oncological Diseases And Methods Of Its Correction
|
№17 / 2010
|
Ye.V.Golovanova
Experience Of Use Of Native Hepatoprotector Heptor (ademetionine) In Patients With Alcoholic Liver Disease
|
№12 / 2010
|
S.V. Kikta, M.JU. Drobizhev, T.A. Belousova
Depressions In Patients With Psoriasis
|
№11 / 2010
|